TILT Holdings Acquires Jupiter Research

The Boldest Acquires DTC Brand Jupiter

August 29, 2024

Consumer Products

Los Angeles-based venture studio The Boldest has acquired Jupiter, a U.S. direct-to-consumer health & wellness CPG brand, in an all-cash deal. The acquisition (closing in September 2024) will support rapid scaling of Jupiter's online and retail sales while founders Simon Saval and Tyler Turner remain as advisors with a minority equity stake.

Canopy Growth to Acquire Jetty Extracts

May 18, 2022

Consumer Products

Canopy Growth Corporation entered into option agreements to acquire up to 100% of Lemurian, Inc. (Jetty), a California-based cannabis extracts and vape brand, with an aggregate upfront consideration of approximately US$69 million for ~75% of Jetty and additional consideration on exercise of the remaining option. The deal gives Canopy a strategic foothold in the California THC market and access to Jetty's solventless extraction technology and premium consumer brand as part of its U.S. THC ecosystem expansion.

BlackRock Alternatives (Diversified Infrastructure) Acquires Jupiter Power from EnCap and Co-Investors

November 15, 2022

Energy

BlackRock Alternatives, through its Diversified Infrastructure business, has agreed to acquire Jupiter Power LLC from EnCap Energy Transition Fund I and co-investors Yorktown Partners and Mercuria Energy. Jupiter Power is a U.S. operator and developer of utility-scale battery energy storage systems (with a 655 MWh operating fleet, 340 MWh under construction and an ~11,000 MW development pipeline); the deal is expected to close in late 2022.

Red Nucleus Acquires Jupiter Life Science Consulting

September 12, 2022

Consulting

Red Nucleus, a Riverside-backed life sciences services platform, has acquired Jupiter Life Science Consulting, a boutique provider of market access and commercialization strategies for pharma, biotech, and medical device clients. The add-on expands Red Nucleus's commercial and market-access capabilities, bringing Jupiter's expertise in payer research, pricing and access strategy, and commercialization planning into the combined platform.

Torrent Pharmaceuticals Acquires Controlling Stake in J. B. Chemicals & Pharmaceuticals from KKR

June 29, 2025

Pharmaceuticals

Torrent Pharmaceuticals has agreed to acquire a controlling stake in J. B. Chemicals & Pharmaceuticals from KKR at an equity valuation of INR 25,689 crore, purchasing a 46.39% stake (with potential to aggregate to 49.19%) followed by a mandatory open offer and a planned merger. The deal strengthens Torrent's presence in the Indian pharmaceutical market and adds JB Pharma's CDMO and international capabilities to Torrent's platform.

Thorlabs Acquires JML Optical Industries

January 16, 2023

Manufacturing

Thorlabs has agreed to acquire JML Optical Industries, a Rochester, New York-based designer and manufacturer of precision optics, with the deal expected to close in January 2023. JML will operate as Thorlabs Lens Systems (TLS) in Rochester, expanding Thorlabs' optics manufacturing footprint and QuickTurn optics capabilities; prior owner Five Points Capital is the selling party noted in reports.